Correspondence 0001104659-22-127897 from Granite Ridge Resources, Inc. (GRNT) (CIK 0001928446) (GRNT)
Granite Ridge Resources, Inc. (GRNT) (CIK 0001928446)
Date: Dec. 16, 2022 · CIK: 0001928446 · Accession: 0001104659-22-127897
AI Filing Summary & Sentiment
File numbers found in text: 333-268478
Referenced dates: December 5, 2022
Show Raw Text
CORRESP
1
filename1.htm
December 16, 2022
VIA EDGAR & FEDERAL EXPRESS
Cheryl Brown
Karina Dorin
Division of Corporation Finance
Office of Energy & Transportation
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549-3561
Re: Granite
Ridge Resources, Inc.
Form S-1 Registration Statement
Filed November 18, 2022
File No. 333-268478
Ladies and Gentlemen:
This letter sets forth the
responses of Granite Ridge Resources, Inc. (the “Company”) to the comments of the Staff (the “Staff”)
of the Securities and Exchange Commission (the “Commission”) set forth in your letter, dated December 5,
2022, with respect to the Company’s registration statement on Form S-1, File No. 333-268478 (the “Registration
Statement”).
Concurrent with the submission
of this letter, we are publicly filing Amendment No. 1 to the Registration Statement (“Amendment No. 1”)
in response to the Staff’s comments. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto
in Amendment No. 1. For your convenience, each of the Staff’s comments is reprinted in bold below, followed by the Company’s
responses thereto.
Registration Statement on Form S-1 filed November 18,
2022
Cover Page
1. For each of the securities being registered for resale, please disclose here the price that the
selling securityholders paid for such securities.
Cheryl Brown
Karina Dorin
U.S. Securities & Exchange Commission
December 16, 2022
Page 2
RESPONSE:
We have revised our disclosure
on the cover page and pages 33-34 of Amendment No. 1 to disclose the purchase price paid by various selling securityholders
for such securities.
2. We note the warrants are out the money. Please disclose the exercise price of the warrants compared to the market price of the
underlying securities. In addition, please disclose the likelihood that warrant holders will not exercise their warrants. Provide similar
disclosure in the prospectus summary, risk factors, MD&A and use of proceeds section and disclose that cash proceeds associated with
the exercises of the warrants are dependent on the stock price. As applicable, describe the impact on your liquidity and update the discussion
on the ability of your company to fund your operations on a prospective basis with your current cash on hand.
RESPONSE:
We have revised our disclosure
on the cover page and pages 12, 37-38, 41 and 127 of Amendment No. 1 to disclose that the cash proceeds associated with the
exercise of the warrants are dependent on the stock price and also to describe any impact on our liquidity.
3. We note the significant number of redemptions of your Class A common stock in connection with
your business combination and that the shares being registered for resale will constitute a considerable percentage of your public float.
Please highlight the significant negative impact sales of shares on this registration statement could have on the public trading price
of the Class A common stock.
RESPONSE:
We have revised our disclosure
on the cover page and pages 33-34 of Amendment No. 1 in response to the Staff’s comment.
Cheryl Brown
Karina Dorin
U.S. Securities & Exchange Commission
December 16, 2022
Page 3
Prospectus Summary, page 2
4. Please expand your discussion here to reflect the fact that this offering involves the potential
sale of a substantial portion of shares for resale and discuss how such sales could impact the market price of the company’s common
stock. Your discussion should highlight the fact that Existing GREP Members, the beneficial owner of over 90% of your outstanding shares,
will be able to sell all of its shares for so long as the registration statement of which this prospectus forms a part is available for
use.
RESPONSE:
We have revised our disclosure
on pages 3, 33-34, 37 and 127 of Amendment No. 1 in response to the Staff’s comment.
Risk Factors
Sales of the Granite Ridge common stock
by the Selling Securityholders..., page 31
5. We note your disclosure that sales of the Granite Ridge common stock by the selling securityholders
(or the perception that such shares may be sold) may cause the market price of Granite Ridge’s securities to drop significantly.
To illustrate the risk of the negative pressure potential sales of shares pursuant to this registration statement could have on the public
trading price of the common shares, disclose the purchase price of the securities being registered for resale and the percentage that
these shares currently represent of the total number of shares outstanding. Also disclose, if true, that even though the current trading
price is significantly below the Executive Network Partnering Corporation IPO price, the private investors have an incentive to sell because
they will still profit on sales because of the lower price that they purchased their securities than the public investors.
RESPONSE:
We have revised our disclosure
the cover page and on pages 33-34 of Amendment No. 1 to disclose the purchase price paid by various selling securityholders
for such shares, the percentage of the total outstanding shares of common stock the shares being registered for resale represent, and
the fact that certain selling securityholders may have an incentive to sell their securities as they purchased their shares at prices
lower than the current public trading price of our common stock.
Cheryl Brown
Karina Dorin
U.S. Securities & Exchange Commission
December 16, 2022
Page 4
General
6. Revise your prospectus to disclose the price that each selling securityholder paid for the shares
being registered for resale. Highlight any differences in the current trading price, the prices that the selling securityholders acquired
their shares and warrants, and the price that public securityholders acquired their shares and warrants. As applicable, please also disclose
that while the selling securityholders may experience a positive rate of return based on the current trading price, the public securityholders
may not experience a similar rate of return on the securities they purchased due to any differences in the purchase prices and the current
trading price. Please also disclose any potential profit the selling securityholders will earn based on the current trading price. Lastly,
please include appropriate risk factor disclosure.
RESPONSE:
We have revised our disclosure
on the cover page and pages 33-35 of Amendment No. 1 in response to the Staff’s comment.
The Company believes the foregoing
fairly responds to the Staff’s comments in its letter dated December 5, 2022 and is prepared to provide the Staff with additional
information. Thank you in advance for your assistance in this matter. If you have any questions or additional comments, please do not
hesitate to contact Amy Curtis, at (214) 969-1763 or Jeremiah Mayfield at (214) 969-1744.
Sincerely,
By:
/s/ Luke Brandenberg
Name: Luke Brandenberg
Title: Chief Executive Officer
cc: Amy Curtis, Holland & Knight LLP
Jeremiah Mayfield, Holland & Knight LLP